EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Antiviral Effect of Berdazimer Sodium on Molluscum Contagiosum Virus Using a Novel In Vitro Methodology

Brian M Ward, Daniel A Riccio iD, Martina Cartwright iD, Tomoko Maeda-Chubachi iD

Viruses · 2023

DOI: 10.3390/v15122360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Brian M Ward und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA. Hauptthemen laut MEDLINE: Molluscum contagiosum virus, Molluscum Contagiosum. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Novan, Durham, NC, USA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molluscum contagiosum (MC) is characterized by skin lesions containing the highly contagious molluscum contagiosum poxvirus (MCV). MCV primarily infects children, with one US Food and Drug Administration (FDA)-approved drug-device treatment in use but no approved medications. Assessing antivirals is hindered by the inability of MCV to replicate in vitro. Here, we use vaccinia virus as a surrogate to provide evidence of the anti-poxvirus properties of berdazimer sodium, a new chemical entity, and the active substance in berdazimer gel, 10.3%, a nitric oxide-releasing topical in phase 3 development for the treatment of MC. We show that berdazimer sodium reduced poxvirus replication and, through a novel methodology, demonstrate that cells infected with drug-treated MCV virions have reduced early gene expression. Specifically, this is accomplished by studying the nuclear factor kappa-light-chain-enhancer of activated B cell (NF-kB)-blocking protein MC160 as an example of an early gene. The results provide a plausible unique antiviral mechanism of action supporting increased MCV resolution observed in patients treated with berdazimer gel, 10.3% and describe a novel methodology that overcomes limitations in investigating MCV response in vitro to a potential new MC topical medication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molluscum contagiosum virusMolluscum ContagiosumUnited StatesChildHumansSiloxanesAntiviral Agents

Stichwörter der Autor:innen

berdazimer sodiummechanism of actionmolluscum contagiosummolluscum contagiosum virusnitric oxide

Substanzen

berdazimer sodiumSiloxanesAntiviral Agents

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
  • Novan, Durham, NC 27703, USA.

ORCID-Profile: Daniel A Riccio, Martina Cartwright, Tomoko Maeda-Chubachi

Förderung

  • NIAID NIH HHS
  • Novan, Durham, NC, USA

Zitieren

APA

Ward, B. M., Riccio, D. A., Cartwright, M., & Maeda-Chubachi, T. (2023). The Antiviral Effect of Berdazimer Sodium on Molluscum Contagiosum Virus Using a Novel In Vitro Methodology. Viruses. https://doi.org/10.3390/v15122360

Vancouver

Ward BM, Riccio DA, Cartwright M, Maeda-Chubachi T. The Antiviral Effect of Berdazimer Sodium on Molluscum Contagiosum Virus Using a Novel In Vitro Methodology. Viruses. 2023. doi:10.3390/v15122360

BibTeX
@article{Ward2023,
  author = {Ward, Brian M and Riccio, Daniel A and Cartwright, Martina and Maeda-Chubachi, Tomoko},
  title = {The Antiviral Effect of Berdazimer Sodium on Molluscum Contagiosum Virus Using a Novel In Vitro Methodology},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15122360}
}
Kostenlos starten →